The four RA patients on TNFα antagonist therapy had severe Aspergillus disease; there were two cases of pulmonary aspergillosis, one case of invasive pulmonary aspergillosis, and one case of intracranial aspergillosis. Here, TNF is linked to rheumatoid arthritis.